Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404855 · ClinicalTrials.gov registry record · NA
Antibiotic Selection Using Next Generation Sequencing vs Urine Culture
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT04404855: Completed NA study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT04404855 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04404855, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
Primary Outcome
Number of participants that develop post surgical infection
Interventions
- OTHER NGS + Antibiotic Recommendation
- PROCEDURE Standard of Care treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT04404855 record still lists
NCT04404855 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which NGS + Antibiotic Recommendation is the first listed.
NCT04404855 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04404855 about?
NCT04404855 is a clinical study titled "Antibiotic Selection Using Next Generation Sequencing vs Urine Culture". This is a randomized controlled clinical study evaluating the use of next-generation sequencing (NGS) to improve antibiotic prescribing before ureteroscopy or percutaneous nephrolithotomy.
What is the current status of trial NCT04404855?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2019-12-18. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04404855?
The interventions under investigation include: NGS + Antibiotic Recommendation (OTHER), Standard of Care treatment (PROCEDURE).
Who is sponsoring clinical trial NCT04404855?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04404855's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI